Metraipolis › archive › dc_f124547beabb

Nanozymes in the Treatment of Pediatric Inflammatory Diseases: Opportunities and Challenges — Europe PMC PMID:42515742

Source
Europe PMC (en)
Original
https://europepmc.org/article/MED/42515742
DOI
10.3390/ph19071061
License (as archived)
solo-consultazione
Archived
2026-10-18T09:30:20.000Z
SHA-256 of the archived text
f5efa05b22b93317f1ffbe0ee6dafd0a577bee4ed77f54327a42afbc75bf30b4
Stable URL of this page
https://metraipolis.com/documento/dc_f124547beabb

How to cite

Nanozymes in the Treatment of Pediatric Inflammatory Diseases: Opportunities and Challenges — Europe PMC PMID:42515742 — Europe PMC (en), https://europepmc.org/article/MED/42515742 (solo-consultazione); archived copy: https://metraipolis.com/documento/dc_f124547beabb (Metraipolis archive dc_f124547beabb, sha256 f5efa05b22b93317f1ffbe0ee6dafd0a577bee4ed77f54327a42afbc75bf30b4)
BibTeX
@misc{dcf124547beabb,
  title = {Nanozymes in the Treatment of Pediatric Inflammatory Diseases: Opportunities and Challenges — Europe PMC PMID:42515742},
  howpublished = {Europe PMC (en)},
  url = {https://europepmc.org/article/MED/42515742},
  note = {License solo-consultazione; archived copy https://metraipolis.com/documento/dc_f124547beabb; sha256 f5efa05b22b93317f1ffbe0ee6dafd0a577bee4ed77f54327a42afbc75bf30b4},
  year = {2026}
}

Archived text

The text is not reproduced here: the archive holds it as solo-consultazione (consultation only, no republication). Read it at the original source: https://europepmc.org/article/MED/42515742. Agents can read the archived copy with the MCP tool read_document.